Optical coherence tomography-based optimization of Mohs micrographic surgery of basal cell carcinoma: A pilot study

Dermatologic Surgery

Volumn 39, Issue 4, 2013, Pages 627-633

  Wang, Katie Xiaoyi ^a,b   Meekings, Adam ^b   Fluhr, Joachim W ^c   McKenzie, Gordon ^b   Lee, David A ^e   Fisher, Juliya ^d   Markowitz, Orit ^d,f   Siegel, Daniel M ^a,d  

^a Long Island Skin Cancer and Dermatologic Surgery   (United States)

^b 11A Grays Farm Production Village   (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Downstate Health Sciences University   (United States)

^e Damascus Dermatology and Skin Surgery Center   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER PATIENT; CARCINOMA; CHEMOSURGERY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DERMATOLOGIST; DIAGNOSTIC VALUE; FEASIBILITY STUDY; FEMALE; HEALTH CARE UTILIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOHS MICROGRAPHIC SURGERY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SKIN BIOPSY; SKIN SURFACE; TREATMENT INDICATION; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; HUMANS; MIDDLE AGED; MOHS SURGERY; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84875811773     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/dsu.12093     Document Type: Article

References (31)

1. Zysk AM, Nguyen FT, Oldenburg AL, Marks DL, et al. Optical coherence tomography: a review of clinical development from bench to bedside. J Biomed Opt 2007; 12: 051403.
2. Gambichler T, Regeniter P, Bechara FG, Orlikov A, et al. Characterization of benign and malignant melanocytic skin lesions using optical coherence tomography in vivo. J Am Acad Dermatol 2007; 57: 629-37.
3. Gambichler T, Jaedicke V, Terras S,. Optical coherence tomography in dermatology: technical and clinical aspects. Arch Dermatol Res 2011; 303: 457-73.
4. Hamdoon Z, Jerjes W, McKenzie G, Jay A, et al. Assessment of tumour resection margins using optical coherence tomography. Head & Neck Oncology 2010; 2: O7.
5. Pomerantz R, Zell D, McKenzie G, Siegel DM,. Optical Coherence Tomography Used as a Modality to Delineate Basal Cell Carcinoma prior to Mohs Micrographic Surgery. Case Reports in Dermatology 2011; 3: 212-8.
6. Mušič MM, Hertl K, Kadivec M, Pavlovic̈ MD, et al. Pre-operative ultrasound with a 12-15 MHz linear probe reliably differentiates between melanoma thicker and thinner than 1 mm. J Eur Acad Dermatol Venereol 2010; 24: 1105-8.
7. Machet L, Belot V, Naouri M, Boka M, et al. Preoperative measurement of thickness of cutaneous melanoma using high-resolution 20 MHz ultrasound imaging: A monocenter prospective study and systematic review of the literature. Ultrasound Med Biol 2009; 35: 1411-20.
8. Marmur ES, Berkowitz EZ, Fuchs BS, Singer GK, et al. Use of high-frequency, high-resolution ultrasound before Mohs surgery. Dermatol Surg 2010; 36: 841-7.
9. Jambusaria-Pahlajani A, Schmults CD, Miller CJ, Shin D, et al. Test characteristics of high-resolution ultrasound in the preoperative assessment of margins of basal cell and squamous cell carcinoma in patients undergoing Mohs micrographic surgery. Dermatol Surg 2009; 35: 9-15.; discussion -6.
10. Telfer NR, Colver GB, Morton CA,. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008; 159: 35-48.
11. Lassau N, Spatz A, Avril MF, Tardivon A, et al. Value of high-frequency US for preoperative assessment of skin tumors. Radiographics 1997; 17: 1559-65.
12. Moore JV, Allan E,. Pulsed ultrasound measurements of depth and regression of basal cell carcinomas after photodynamic therapy: relationship to probability of 1-year local control. Br J Dermatol 2003; 149: 1035-40.
13. Bobadilla F, Wortsman X, Munoz C, Segovia L, et al. Pre-surgical high resolution ultrasound of facial basal cell carcinoma: correlation with histology. Cancer Imaging 2008; 8: 163-72.
14. Diaconeasa A, Boda D, Neagu M, Constantin C, et al. The role of confocal microscopy in the dermato-oncology practice. J Med Life 2011; 4: 63-74.
15. Rajadhyaksha M,. Confocal microscopy of skin cancers: translational advances toward clinical utility. Conf Proc IEEE Eng Med Biol Soc 2009; 2009: 3231-3.
16. Mogensen M, Thrane L, Jorgensen TM, Andersen PE, et al. OCT imaging of skin cancer and other dermatological diseases. J Biophotonics 2009; 2: 442-51.
17. Mogensen M, Thrane L, Joergensen TM, Andersen PE, et al. Optical coherence tomography for imaging of skin and skin diseases. Semin Cutan Med Surg 2009; 28: 196-202.
18. Tomlins PH, Woolliams P, Tedaldi M, Beaumont A, et al. Measurement of the three-dimensional point-spread function in an optical coherence tomography imaging system. Proc SPIE 2008; 6847: 68472Q.
19. Holmes J, Hattersley S, Stone N, Bazant-Hegemark F, et al. Multi-channel Fourier domain OCT system with superior lateral resolution for biomedical applications. In:, Izatt JA, Fujimoto JG., Tuchin VV, editors. Coherence Domain Optical Methods and Optical Coherence Tomography in Biomedicine XII. Bellingham, WA: SPIE; 2008. p. 68470O.
20. Holmes J,. Theory and applications of multi-beam OCT. In:, Podoleanu A, editor. 1st Canterbury Workshop on Optical Coherence Tomography and Adaptive Optics. Canterbury, United Kingdom: SPIE; 2008. p. 713908-7.
21. Jerjes W, Upile T, Conn B, Hamdoon Z, et al. In vitro examination of suspicious oral lesions using optical coherence tomography. Br J Oral Maxillofac Surg 2009; 48: 18-25.
22. Standish BA, Lee KK, Mariampillai A, Munce NR, et al. In vivo endoscopic multi-beam optical coherence tomography. Phys Med Biol 2010; 55: 615-22.
23. Hamdoon Z, Jerjes W, Upile T, Hopper C,. Optical coherence tomography-guided photodynamic therapy for skin cancer: Case series. Photodiagn Photodyn Ther 2011; 8: 229.
24. Hamdoon Z, Jerjes W, Upile T, Hopper C,. Risk assessment of oral epithelium thickness using in vivo OCT. Photodiagn Photodyn Ther 2011; 8: 229-30.
25. Gambichler T, Orlikov A, Vasa R, Moussa G, et al. In vivo optical coherence tomography of basal cell carcinoma. J Dermatol Sci 2007; 45: 167-73.
26. Olmedo JM, Warschaw KE, Schmitt JM, Swanson DL,. Correlation of thickness of basal cell carcinoma by optical coherence tomography in vivo and routine histologic findings: a pilot study. Dermatol Surg 2007; 33: 421-5.; discussion 5-6.
27. Gambichler T, Moussa G, Regeniter P, Kasseck C, et al. Validation of optical coherence tomography in vivo using cryostat histology. Phys Med Biol 2007; 52: N75-85.
28. Olmedo JM, Warschaw KE, Schmitt JM, Swanson DL,. Optical coherence tomography for the characterization of basal cell carcinoma in vivo: a pilot study. J Am Acad Dermatol 2006; 55: 408-12.
29. Aydin SZ, Ash Z, Del Galdo F, Marzo-Ortega H, et al. Optical Coherence Tomography: A New Tool to Assess Nail Disease in Psoriasis? Dermatology 2011; 222: 311-13.
30. Castillo-Gallego C, Aydin S, Ash Z, Abignano G, et al. A Comparison of Optical Coherence Tomography and Clinical Assessment of Nail Disease in Psoriasis and Psoriatic Arthritis. The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis Conference. Naples, FL; 2011.
31. Mogensen M, Joergensen TM, Nurnberg BM, Morsy HA, et al. Assessment of optical coherence tomography imaging in the diagnosis of non-melanoma skin cancer and benign lesions versus normal skin: observer-blinded evaluation by dermatologists and pathologists. Dermatol Surg 2009; 35: 965-72.